NCT07390071 Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy Status RECRUITING Phase NA
NCT06706102 Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome Status RECRUITING Phase PHASE4
NCT06703216 Pre-emptive Anakinra for Cytokine Event Reduction Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06352866 Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM Status WITHDRAWN Phase PHASE2
NCT05643092 Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome Status RECRUITING Phase N/A